NGM Crosses Above Average Analyst Target
July 08, 2021 at 09:43 AM EDT
In recent trading, shares of NGM Biopharmaceuticals Inc (NGM) have crossed above the average analyst 12-month target price of $21.80, changing hands for $21.83/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..